Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

V. cholerae transcriptome or deleted for the tgt gene in MH, supplemented or not with tobramycin or ciprofloxacin

ABSTRACT: V. cholerae transcriptome or deleted for the tgt gene in MH, supplemented or not with tobramycin or ciprofloxacin

PROVIDER: PRJNA885798 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21765949.fastq.gz	Fastqsanger.gz
	SRR21765950.fastq.gz	Fastqsanger.gz
	SRR21765951.fastq.gz	Fastqsanger.gz
	SRR21765952.fastq.gz	Fastqsanger.gz
	SRR21765953.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

V. cholerae transcriptome or deleted for the tgt gene in MH, supplemented or not with tobramycin or ciprofloxacin

Project description:We study gene expression levels of V. cholerae N16961 WT and tgt mutant strains in MH medium in the presence or not of sublethal concentration on tobramycin or ciprofloxacin

2022-10-03 | GSE214520 | GEO

V. cholerae transcriptome of WT and modification deletion mutants with sub-MIC tobramycin or ciprofloxacin

Project description:We study gene expression levels of V. cholerae N16961 hapR+ corrected strain in exponential phase with tobramycin or ciprofloxacin.

2025-06-18 | GSE275883 | GEO

Effect of sub-MIC tobramycin treatment on E. coli MG1655 WT and NCM3416

Project description:Effect of sub-MIC tobramycin treatment on E. coli MG1655 WT (strain classically used as WT strain) and NCM3416 (corrected rph strain). Comparison of genes expression without treatment (MH) in E. coli MG1655 WT and NCM3416.

2023-03-01 | GSE224240 | GEO

V. cholerae transcriptome in MH, supplemented or not with glucose 0.4% or maltose 0.4%

Project description:We study gene expression levels of V. cholerae N16961 WT and crp mutant strains/V. cholerae N16961 hapR+ corrected strain, ravAviA mutant and ravAviA overexpressing strains in exponential phase in MH, MH+maltose 0.4% and MH+glucose 0.4%

2022-02-16 | GSE196651 | GEO

Transcriptional profiling of Campylobacter jejuni wild-type 81-176 and its ciprofloxacin-resistant derivative (P3) in the presence and absence of ciprofloxacin

Project description:Campylobacter jejuni is one of the most important zoonotic enteric bacterial pathogens able to colonize the gastrointestinal tract of various animals. The number of campylobacteriosis cases has increased worldwide and the particular concern has been the high level of fluoroquinolone resistance observed in C. jejuni isolates. In this study, we explored the effect of ciprofloxacin in Campylobacter jejuni by gene expression microarray analysis. The comparisons of transcriptional responses were performed in the absence and presence of ciprofloxacin with the wild-type strain 81-176 and its intermediate-resistant variant (P3). The resistant variant contained a single-nucleotide mutation causing amino acid change Asp-90-Asn in the gyrA gene instead of the most common Thr-86-Ile, causing a high-level resistance to ciprofloxacin. After the short-term exposure to a relatively high concentration of ciprofloxacin, the viability of C. jejuni 81-176 wild-type cells remained notably high when compared with other gram-negative bacteria. The general responses of short-term ciprofloxacin exposure were determined from both genetic backgrounds and resulted in the expression variation of genes participating in general cellular processes, e.g. , in carbon and amino-acid metabolism and protein transport. Ciprofloxacin effect for gene expression was measured from both genetic backgrounds after 1 hour exposure at the level of 0 and 8 Âµg/ml ciprofloxacin in MH-broth. For RNA isolation, 5 independent experiments with and without ciprofloxacin were performed, and 4 replicates of each total RNA was applied for the gene expression study.

2012-12-31 | E-GEOD-41822 | biostudies-arrayexpress

Tobramycin Treatment of Planktonic Pseudomonas aeruginosa

Project description:As a comparison to tobramycin-treated P. aeruginosa biofilms, we investigated the response of planktonic P. aeruginosa to tobramycin by microarray. Keywords: Tobramycin Response

2008-06-10 | GSE9991 | GEO

V. cholerae transcriptome of WT and modification deletion mutants with sub-MIC tobramycin or ciprofloxacin

Project description:V. cholerae transcriptome of WT and modification deletion mutants with sub-MIC tobramycin or ciprofloxacin

| PRJNA1153468 | ENA

Copper oxide nanoparticles treated MH-S cells

Project description:The three groups of MH-S cells were control group, 20 μg/ml CuO NPs group, and 20 μg/ml CuO NPs + 10 μM TTM group. Total RNA of the MH-S cells were extracted using cell RNA isolation kit (Vazyme Biotech Co., Ltd, China). The number of MH-S cell sample for each group were three (n = 3 cell samples/group). All samples were sent to Majorbio Biotech (Shanghai, China) for transcriptome sequencing.

2025-01-17 | GSE287049 | GEO

MH-seq data of bread wheat

Project description:Identification of open chromatin in wheat spikes and seedlings using MH-seq

2024-10-08 | GSE186694 | GEO

Colletotrichum fioriniae MH 18 strain:MH 18

Project description:Colletotrichum fioriniae MH 18 strain:MH 18 Genome sequencing

| PRJNA196041 | ENA